http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31129114

Outgoing Links

Predicate Object
contentType Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 147
issn 1875-8908
1387-2877
issueIdentifier 1
pageRange 139-147
publicationName Journal of Alzheimer's disease : JAD
startingPage 139
bibliographicCitation Xiao J, Katsumata N, Bernier F, Ohno K, Yamauchi Y, Odamaki T, Yoshikawa K, Ito K, Kaneko T. Probiotic Bifidobacterium breve in Improving Cognitive Functions of Older Adults with Suspected Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial. J Alzheimers Dis. 2020;77(1):139–47. PMID: 32623402; PMCID: PMC7592675.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9eac7d92b801f5a9469c339d38626106
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2b79900430549e3a9cc1c8c09682cbc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4cbc01547c6ad2d0ef1ac648186c96fa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a589fc8ae87ea97fd2ba9e12fd9c7d96
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_818e9e7bce49f46f1b4afe5cf5bea1ab
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2cbdcc567bb07a256976354ddfd63a22
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8707-902X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7a08a4830c21bb7cd2294193e641991
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e862ea4da54aff8a3845ac90ffffcc39
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c502af5b802cfe766ec0a56c5c97ed4
date 2020-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/32623402
https://doi.org/10.3233/jad-200488
https://pubmed.ncbi.nlm.nih.gov/PMC7592675
isPartOf https://portal.issn.org/resource/ISSN/1387-2877
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
https://portal.issn.org/resource/ISSN/1875-8908
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Probiotic Bifidobacterium breve in Improving Cognitive Functions of Older Adults with Suspected Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D060825Q000175
http://id.nlm.nih.gov/mesh/D060825Q000178
http://id.nlm.nih.gov/mesh/D000069984
http://id.nlm.nih.gov/mesh/D019936Q000008
http://id.nlm.nih.gov/mesh/D003071Q000502
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D060825Q000523
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11385
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7404
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7203
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173

Total number of triples: 46.